1 septiembre 2014
The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study group has now discovered that the risk of this protein does not — as previously assumed — depend on its presence within the tumor cell, but rather from its activity in the cells adjacent to the tumor.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/jJKMVEqLKIo/140901090303.htm
